Robert F. Kennedy Jr., Trump's pick to head the Department of Health and Human Services, faces scrutiny for fees he may earn from lawsuits against Merck.

Khalistani terrorist Gurpatwant Pannun was spotted at US President Donald Trump's inauguration, raising anti-India slogans. His attendance aimed to demonstrate a supposed connection to Trump ...

Like a catchy tune or a clever pun, a good slogan can cement itself in your brain. Slogans like “I’m lovin’ it,” “Got milk?” and “What’s in your wallet?” are so familiar they might not feel like ads ...

In his first speech as the 47th President of the United States, Donald Trump reiterated one of his presidential campaign slogans — “drill, baby, drill” — indicating that he will push for more oil and ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

Gurpatwant Singh Pannun, a designated Khalistani terrorist, shockingly appeared at Donald Trump's inauguration, chanting pro-Khalistan slogans. His presence at the high-profile event sparked ...

Everyone who wants to lead the party is embarrassed of their own record You can save this article by registering for free here. Or sign-in if you have an account. The only person more toxic to ...

Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.

And it was also the slogan of Hungary's presidency of the EU in 2024 Prime Minister Viktor Orban, who is regarded as a hard-right populist by political scientists. Musk's megaphone sloganeering ...

Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...